Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

March 31, 1996

Primary Completion Date

January 31, 2001

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

recombinant interferon alfa

DRUG

chemotherapy

DRUG

isotretinoin

Trial Locations (27)

1000

Institut Jules Bordet, Brussels

1125

National Institute of Oncology, Budapest

2020

Algemeen Ziekenhuis Middelheim, Antwerp

5001

Kantonspital Aarau, Aarau

21100

Ospedale di Circolo e Fondazione Macchi, Varese

81190

Marmara University Hospital, Istanbul

115478

Russian Academy of Medical Sciences Cancer Research Center, Moscow

B-9300

Onze Lieve Vrouw Ziekenhuis Aalst, Aalst

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

B-3000

U.Z. Gasthuisberg, Leuven

5211 NL

Groot Ziekengasthuis 's-Hertogenbosch, 's-Hertogenbosch

1066 CX

Antoni van Leeuwenhoekhuis, Amsterdam

1105 AZ

Academisch Medisch Centrum, Amsterdam

2300 CA

Leiden University Medical Center, Leiden

NL-6252 HB

University Medical Center Nijmegen, Nijmegen

3000 CA

University Hospital - Rotterdam Dijkzigt, Rotterdam

3075 EA

Rotterdam Cancer Institute, Rotterdam

3508 GA

Academisch Ziekenhuis Utrecht, Utrecht

N-0310

Norwegian Radium Hospital, Oslo

CH-6500

Ospedale San Giovanni, Bellinzona

CH-3010

Inselspital, Bern, Bern

CH-7000

Ratisches Kantons und Regionalspital, Chur

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

CH-9007

Kantonsspital - Saint Gallen, Sankt Gallen

CH-8091

Universitaetsspital, Zurich

BS2 8HW

Bristol Royal Infirmary, Bristol

G11 6NT

Beatson Oncology Centre, Glasgow

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK